Former Facebook CFO Ebersman Launches New Health Tech Startup Lyra Health
Kara Swisher / Re/code :
Context & Ripple Effects
When David Ebersman left Facebook's CFO seat in 2015 to found Lyra Health, he was betting that a network built around treating mental health could be run like a scaled consumer-internet operation. The bet was unusual for its time: most Big Tech alumni stayed in consumer software rather than clinical care delivery.
The subsequent coverage validates the arc — $75M Series C in 2020 with a stated $100M revenue expectation, then a $235M Series F led by Dragoneer at a $5.85B valuation in 2022 — with employers like Uber, eBay, and Morgan Stanley as distribution channels. This launch piece is the origin point of one of the largest employer-based mental health platforms.
First-order effects
- Facebook immediately needs a CFO successor at a moment when it is scaling ad revenue aggressively, while Ebersman trades public-company finance for an unproven clinical network where his credibility is the startup's main asset.
- Lyra's founding thesis — matching patients to effective providers via data rather than traditional referral — puts it directly against incumbent employee-assistance programs from day one.
Second-order effects
- Employers become the buyers: by selling mental health access as a benefits line item, Lyra makes HR departments the procurement gate for clinical care, a channel Uber, eBay, and Morgan Stanley all adopted as customers.
- Successive large rounds ($45M Series B, $75M Series C, $235M Series F) force competing behavioral-health startups to raise at comparable scale or concede the enterprise segment, concentrating capital in network-model providers.
Third-order effects
- Ebersman's path establishes a template for senior tech operators exiting platform companies to run regulated-care businesses, shifting where executive talent and venture dollars flow within health tech.
- If the pattern holds, mental health care consolidates into a handful of employer-distributed networks, with payers and health systems negotiating against platforms rather than individual clinics — though whether that improves outcomes remains an open question the corpus does not answer.
The trend: Senior technology executives are increasingly leaving platform giants to build employer-distributed health businesses, with Lyra's rise from 2015 launch to multi-billion-dollar valuation as the defining proof case.